Clinical features of the comorbid state in children with hemophilia in the Kyrgyz Republic

Abstract

The paper presents data on the occurrence of hemophilia in Kyrgyzstan. 130 children were diagnosed with hemophilia. All patients were divided into two groups: hemophilia A (110 — 84.6%) and hemophilia B (20 — 15.4%). Age of children — from 7 months of age to 17 years. In the analysis, it was found that each comorbid disease in a patient with hemophilia can cause a worsening of the underlying disease. Children need not only pathogenetic therapy but also the treatment of comorbidities. Our study also confirms the fact that comorbidity in patients with hemophilia is one of the unfavorable risk factors during, complication and severity of the disease, up to death. Also, the combination of two or more diseases plays a significant role in the frequency, duration and severity of bleeding in a patient, despite ongoing pathogenetic therapy.